- Language
About Dr Anne Capp
Profile: Dr Anne Capp completed training in Radiation Oncology at St Vincent’s and St George Hospitals in Sydney, after graduating from The University of Tasmania in 1987.She then spent two years as a clinical research fellow at the Royal Marsden Hospital UK, returning to Australia in 1997 to take up a Staff Specialist position at the Illawarra Cancer Care Centre, Wollongong.In 2006 she moved to the Hunter region to take up a Senior Staff Specialist position at Calvary Mater Newcastle and from 2010 – 2012 was the Director of the Department of Radiation Oncology.Dr Capp’s interests include treatment of urological malignancies, lymphoma, gastro-intestinal tumours, gynaecological malignancies and breast cancer. She is actively involved in clinical trial development and recruitment.
Practice Location
- Practice name Lake Macquarie Private Hospital
- Address Lake Macquarie Private Hospital, 36 Pacific Highway, Genesis Cancer Care Newcastle, Gateshead, NSW
- Suburb or City Gateshead, NSW
- State New South Wales
- Country Australia
- What is the Dr Anne Capp's specialty?
- Dr Anne Capp is a Radiologist, Medical Oncologist.
- What is the address of the Dr Anne Capp's practice?
- Dr Anne Capp works at Lake Macquarie Private Hospital, 36 Pacific Highway, Genesis Cancer Care Newcastle, Gateshead, NSW
- What are the Dr Anne Capp's qualifications?
-
Profile: Dr Anne Capp completed training in Radiation Oncology at St Vincent’s and St George Hospitals in Sydney, after graduating from The University of Tasmania in 1987.She then spent two years as a clinical research fellow at the Royal Marsden Hospital UK, returning to Australia in 1997 to take up a Staff Specialist position at the Illawarra Cancer Care Centre, Wollongong.In 2006 she moved to the Hunter region to take up a Senior Staff Specialist position at Calvary Mater Newcastle and from 2010 – 2012 was the Director of the Department of Radiation Oncology.Dr Capp’s interests include treatment of urological malignancies, lymphoma, gastro-intestinal tumours, gynaecological malignancies and breast cancer. She is actively involved in clinical trial development and recruitment.